ClinicalTrials.gg
SuspendedNCT07620964Updated Sep 4, 2026

Testing and Evaluating an Interactive Media Use Journal for Adolescents

An interventional study of Interactive Media Use Journal (IMUJ) in Social Media and Adolescent Behavior, sponsored by University of Wisconsin, Madison. Suspended at 1 site in United States. Open to participants aged 13 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-04.

Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Treatment

Why this study was suspended
Interim Analysis
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
13 Years to 18 Years
Sex
All
01

Study summary

The goal of this study is to test the feasibility and acceptability of an Interactive Media Use Journal (IMUJ) co-developed with youth.

This study is part of a larger effort using Intervention Mapping to co-develop this resource, test it for feasibility and acceptability via this proposed protocol, and then eventually disseminate the resource in partnership with the American Academy of Pediatrics.

50 participants between the ages of 13-18 will be recruited for this study

Read the detailed description

Adolescent social media engagement is ubiquitous, and a growing body of extant research documents how its use interacts with health outcomes. However, there is a dearth of exploration into interventions to encourage behavioral change in youth media use habits. This study, therefore, investigates whether the use of an Interactive Media Use Journal is feasible and acceptable. This study is the first step towards a large goal to understand whether a tool like an Interactive Media Use Journal can foster adolescent self-efficacy in managing media use as part of an Intervention Mapping process.

02

Conditions studied

  • Social Media
  • Adolescent Behavior

Keywords

  • social media engagement
  • health
  • behavior change
  • habit
  • intervention mapping
03

In context

Adolescent Behavior

305 studies on the registry are indexed under Adolescent Behavior; 47 are open to participants now.

This study's planned enrollment of 50 is below the median of 172 across 256 interventional studies indexed under Adolescent Behavior.

Browse Adolescent Behavior studies →

Lead sponsor

University of Wisconsin, Madison is the lead sponsor of 1,188 studies on the registry; 181 are open to participants now.

Of its 157 completed or terminated interventional studies of FDA-regulated products, 118 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • English speaking
  • has internet access
  • in the United States

Exclusion criteria

Exclusion Criteria:

  • youth under the age of 13 years
  • over the age of 18 years
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Youth using digital technology

    Behavioral: Interactive Media Use Journal (IMUJ)

Interventions

  • BehavioralInteractive Media Use Journal (IMUJ)

    6 week journal experience to track social media use and reflect on mental health self-assessment

06

What researchers measure

Primary outcomes

  1. Feasibility Assessment: What made it difficult to complete the diary?

    Summary of all reasons (lack of time, forgot to compete it, did not find it engaging, technical issues, emotional discomfort, no major barriers, other) tallied by participant count for each reason reported.

    Time frame: post-journal survey response, up to 8 weeks

  2. Acceptability Score

    16-items scored on a 5 point likert scale from 1-5 (total range of scores from 16-80) where higher scores indicate higher acceptability.

    Time frame: post-journal survey response, up to 8 weeks

07

Study locations

1 site
  • University of Wisconsin
    Madison, Wisconsin 53705, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2026 (actual). Primary completion is estimated for Sep 2026, 2 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 27, 2026
First posted
Jun 2, 2026
StartActual
Jul 19, 2026
Primary completionEst.
Sep 2026
CompletionEst.
Sep 2026
Last update
Sep 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07620964
Responsible party
Sponsor
First posted
Jun 2, 2026
Start date
Jul 19, 2026
Primary completion
Sep 2026 (estimated)
Completion
Sep 2026 (estimated)
Last update
Sep 4, 2026

Study contacts

Megan Moreno, MD, MSEd, MPH
principal investigator · University of Wisconsin, Madison

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is suspended, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion